Private Advisor Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68M | Buy |
399,225
+184,500
| +86% | +$1.7M | 0.02% | 692 |
|
|
2025
Q1 | $1.84M | Buy |
214,725
+184,800
| +618% | +$1.59M | 0.01% | 935 |
|
|
2024
Q4 | $321K | Sell |
29,925
-17,488
| -37% | -$188K | ﹤0.01% | 1814 |
|
|
2024
Q3 | $269K | Buy |
47,413
+4,442
| +10% | +$25.2K | ﹤0.01% | 2018 |
|
|
2024
Q2 | $181K | Buy |
42,971
+46
| +0.1% | +$194 | ﹤0.01% | 2171 |
|
|
2024
Q1 | $218K | Buy |
42,925
+1,945
| +5% | +$9.9K | ﹤0.01% | 2061 |
|
|
2023
Q4 | $382K | Sell |
40,980
-1,850
| -4% | -$17.2K | ﹤0.01% | 1636 |
|
|
2023
Q3 | $281K | Buy |
42,830
+11,150
| +35% | +$73K | ﹤0.01% | 1651 |
|
|
2023
Q2 | $258K | Sell |
31,680
-7,500
| -19% | -$61K | ﹤0.01% | 1718 |
|
|
2023
Q1 | $336K | Sell |
39,180
-78,700
| -67% | -$674K | ﹤0.01% | 1516 |
|
|
2022
Q4 | $1.09K | Sell |
117,880
-16,800
| -12% | -$156 | ﹤0.01% | 1228 |
|
|
2022
Q3 | $1.39M | Sell |
134,680
-51,800
| -28% | -$535K | 0.02% | 766 |
|
|
2022
Q2 | $1.87M | Buy |
186,480
+63,225
| +51% | +$633K | 0.02% | 787 |
|
|
2022
Q1 | $1.52M | Buy |
+123,255
| New | +$1.52M | 0.01% | 914 |
|
|
2020
Q3 | – | Sell |
-3,000
| Closed | -$15K | – | 1712 |
|
|
2020
Q2 | $15K | Buy |
+3,000
| New | +$15K | ﹤0.01% | 2710 |
|